Skip to main content

Pairings: Jun 17, 2009


UK-based DxS announced last week the appointment of Ron Long as the company's new chairman.

Prior to this appointment, Long served as non-executive director of DxS since July 2008. While serving as the new chairman, Long will retains his positions at Medivir and Procognia Israel. He will replace DxS' current chairman David Evans, who is stepping down from the position.

Long has four decades of industry experience, working at firms such as Wellcome Foundation and Amersham where he was vice chairman. DxS did not say why Evans was stepping down.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.